Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.

Author: ClassenSimon, EwertRalf, GallHenning, GhofraniHossein-Ardeschir, GrimmingerFriedrich, MayerEckhard, RichterManuel J, SeegerWerner, WarnkeChristian

Paper Details 
Original Abstract of the Article :
In patients with severe pulmonary arterial hypertension, subcutaneous or catheter-based intravenous application of prostanoids carries a risk of local side effects or systemic infections, which limits their use and acceptance. Recently, a fully implantable pump for continuous application of intraven...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00392-016-1037-2

データ提供:米国国立医学図書館(NLM)

A Fully Implantable Pump for Pulmonary Hypertension: Evaluating its Safety

Pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries of the lungs, can be a challenging and debilitating disease. This study focuses on the safety of a fully implantable pump designed for the continuous intravenous delivery of treprostinil, a drug used to treat PAH. The researchers recognized the limitations of traditional treatment methods, such as subcutaneous or catheter-based administration, which can lead to local side effects or systemic infections. This quest for a safer and more effective treatment option for PAH is analogous to a desert nomad seeking a reliable and sustainable source of water in a harsh and unforgiving environment.

A Promising Approach to PAH Treatment

The researchers investigated the safety of the implantable pump in patients with severe PAH, evaluating the procedure itself as well as potential complications. Their findings suggest that the pump can be safely implanted under local or general anesthesia, offering a viable alternative to traditional treatment methods. This discovery, much like the discovery of a hidden oasis in the heart of a desert, holds the potential to significantly improve the lives of patients with PAH.

Improved Quality of Life for PAH Patients

The development of this safe and effective implantable pump offers hope for patients with PAH. It may provide a more comfortable and convenient treatment option, leading to improved quality of life and potentially prolonging survival. Just as the discovery of an oasis brings a sense of relief and rejuvenation to weary desert travelers, this new treatment option could offer a similar sense of hope and renewal for those struggling with PAH.

Dr. Camel's Conclusion

This study highlights the potential of a fully implantable pump for the treatment of PAH. By providing a safer and more effective treatment option, this innovation could significantly improve the lives of patients with this debilitating disease. The quest for innovative solutions in healthcare is an ongoing journey, much like a desert nomad's endless search for the next oasis, driven by a desire to improve the human condition.
Date :
  1. Date Completed 2017-03-28
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

27670656

DOI: Digital Object Identifier

10.1007/s00392-016-1037-2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.